Form 4/A for AGL agilon health, inc.
Accepted 2023-01-09 00:00:00 ET · period of report 2022-12-15 · accession 0001209191-23-002592 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMA | 2023-01-09 | 2022-12-16 | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $5.23 | +5,398 | 15.8K | +52% | +$28.2K |
| DMA | 2023-01-09 | 2022-12-16 | AGL | Kornitzer Benjamin | Chief Med, Quality Off | M - OptEx | $0.00 | -5,398 | 275.0K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-16 | M | A | 4,511 | $4.49 | 14,937 | D | — | — | (F1) Includes restricted stock units. |
| 2 | Common | Common Stock | 2022-12-16 | M | A | 887 | $8.99 | 15,824 | D | — | — | (F1) Includes restricted stock units. |
| 3 | Derivative | Options (Rights to Buy) | 2022-12-16 | M | D | 887 | $0.00 | 249,113 | D | $8.99 · — to 2030-01-31 | 887 Common Stock | (F3) These options were granted on January 31, 2020 and vested on September 14, 2021. |
| 4 | Derivative | Options (Rights to Buy) | 2022-12-16 | M | D | 4,511 | $0.00 | 275,000 | D | $4.49 · — to 2030-01-31 | 4,511 Common Stock | (F2) These options were granted on January 31, 2020 and vest in four equal installments on January 31 of each of 2021, 2022, 2023, and 2024. |